A Single-patient Study of Repeat-dose Administration of Prometic Plasminogen (Human) Intravenous

Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients at a Dose of 4E13 vg/kg

NCT03392974 ·Status: COMPLETED ·Phase: PHASE3

Natural History Study of Factor IX Treatment and Complications

NCT02502409 ·Status: UNKNOWN

Dose-Response Study of Recombinant Factor VIII Manufactured Protein-Free (rAHF-PFM) in Patients With Hemophilia A

NCT00289536 ·Status: COMPLETED ·Phase: PHASE4

Thrombocytopenia and Bleeding in Wiskott-Aldrich Syndrome (WAS) Patients

NCT00909363 ·Status: TERMINATED ·Phase: PHASE2

Factor IX as Adjunctive Therapy to Emicizumab (EMIX)

NCT05281718 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Pharmacokinetic Study of ADVATE Reconstituted in 2 mL Sterile Water for Injection

NCT00952822 ·Status: COMPLETED ·Phase: PHASE1

Study to Test the Safety of an Investigational Drug Given Repeatedly to Adult Men With Severe Hemophilia

NCT03996486 ·Status: WITHDRAWN ·Phase: PHASE1

Hemlibra in Mild Hemophilia A

NCT04567511 ·Status: RECRUITING ·Phase: PHASE4

Compassionate Use of Defibrotide for Patients With Veno-occlusive Disease of the Liver

NCT00143546 ·Status: NO_LONGER_AVAILABLE

An Open Enrollment Study of Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency

NCT00945906 ·Status: COMPLETED ·Phase: PHASE3

Safety of a New Type of Treatment Called Gene Transfer for the Treatment of Severe Hemophilia B

NCT00076557 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Once-A-Day Prophylaxis for Youth and Young Adults With Severe Hemophilia A

NCT00717626 ·Status: COMPLETED ·Phase: PHASE2

Phase 1 Safety, Pharmacokinetics And Pharmacodynamics Study Of Recombinant Factor VIIa Variant (813d) In Adult Subjects With Hemophilia

NCT01439971 ·Status: COMPLETED ·Phase: PHASE1

A Single-dose, Dose-escalation Study of a Long-acting MOD-5014 in Healthy Adult Male

NCT02919800 ·Status: COMPLETED ·Phase: PHASE1

A Study of Repeat Dosing of PEG Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection

NCT05265286 ·Status: COMPLETED ·Phase: PHASE2

Assess the Efficacy and Safety of Personalized Prophylaxis Human-cl rhFVIII in Patients With Severe Haemophilia A

NCT02256917 ·Status: COMPLETED ·Phase: PHASE3

Dose Response to Recombinant Factor VIIa When Administered for Bleed

NCT00104455 ·Status: COMPLETED ·Phase: PHASE1

Lead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Participants

NCT03876301 ·Status: COMPLETED

Safety of 40K Pegylated Recombinant Factor IX in Non-Bleeding Patients With Haemophilia B

NCT00956345 ·Status: COMPLETED ·Phase: PHASE1

Fibrinogen Concentrate (Human) - Efficacy and Safety Study

NCT00916656 ·Status: WITHDRAWN ·Phase: PHASE3

Study of Next-Generation Recombinant Factor IX Variant in Adult Subjects With Hemophilia B

NCT03995784 ·Status: COMPLETED ·Phase: PHASE2

Case and Use Scenario Study to Gain Knowledge on the User Needs for a Medical Device for Hemophilia a Monitoring

NCT06369740 ·Status: COMPLETED

A Phase I Safety, Pharmacokinetics and Pharmacodynamics Study of Recombinant Factor VIIa in Adult Patients With Hemophilia A or B

NCT01708564 ·Status: COMPLETED ·Phase: PHASE1

A Safety, Tolerability, and Pharmacokinetics Study of a Single Intravenous Injection of Recombinant Coagulation Factor VIII Fc - Von Willebrand Factor - XTEN Fusion Protein (rFVIIIFc-VWF-XTEN) (BIVV001) in Previously Treated Adults With Severe Hemophilia A (EXTEN-A)

NCT03205163 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

An Observational Cohort Study of the Safety and Efficacy of Fibrinogen Concentrate, Human (FCH) in Subjects With Congenital Fibrinogen Deficiency

NCT02427217 ·Status: COMPLETED